Sanglier J J, Haag H, Huck T A, Fehr T
Preclinical Research, Sandoz Pharma Ltd, Basel, Switzerland.
Res Microbiol. 1993 Oct;144(8):633-42. doi: 10.1016/0923-2508(93)90066-b.
Novel secondary metabolites continue to be isolated from Actinomycetes. Their biological activities and chemical structures show a wide range of diversity. This short review provides information on the compounds isolated between 1988 and 1992, and highlights interesting substances discovered during screening.
